Insulin resistance induced by growth hormone is linked to lipolysis and associated with suppressed pyruvate dehydrogenase activity in skeletal muscle: a 2 × 2 factorial, randomised, crossover study in human individuals
- 18 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 63 (12), 2641-2653
- https://doi.org/10.1007/s00125-020-05262-w
Abstract
Aims/hypothesis Growth hormone (GH) causes insulin resistance that is linked to lipolysis, but the underlying mechanisms are unclear. We investigated if GH-induced insulin resistance in skeletal muscle involves accumulation of diacylglycerol (DAG) and ceramide as well as impaired insulin signalling, or substrate competition between fatty acids and glucose. Methods Nine GH-deficient male participants were randomised and examined in a 2 × 2 factorial design with and without administration of GH and acipimox (an anti-lipolytic compound). As-treated analyses were performed, wherefore data from three visits from two patients were excluded due to incorrect GH administration. The primary outcome was insulin sensitivity, expressed as the AUC of the glucose infusion rate (GIRAUC), and furthermore, the levels of DAGs and ceramides, insulin signalling and the activity of the active form of pyruvate dehydrogenase (PDHa) were assessed in skeletal muscle biopsies obtained in the basal state and during a hyperinsulinaemic–euglycaemic clamp (HEC). Results Co-administration of acipimox completely suppressed the GH-induced elevation in serum levels of NEFA (GH versus GH+acipimox, p < 0.0001) and abrogated GH-induced insulin resistance (mean GIRAUC [95% CI] [mg min−1 kg−1] during the HEC: control, 595 [493, 718]; GH, 468 [382, 573]; GH+acipimox, 654 [539, 794]; acipimox, 754 [618, 921]; GH vs GH+acipimox: p = 0.004). GH did not significantly change either the accumulation of DAGs and ceramides or insulin signalling in skeletal muscle, but GH antagonised the insulin-stimulated increase in PDHa activity (mean ± SEM [% from the basal state to the HEC]: control, 47 ± 19; GH, −15 ± 21; GH+acipimox, 3 ± 21; acipimox, 57 ± 22; main effect: p = 0.02). Conclusions/interpretation GH-induced insulin resistance in skeletal muscle is: (1) causally linked to lipolysis; (2) not associated with either accumulation of DAGs and ceramides or impaired insulin signalling; (3) likely to involve substrate competition between glucose and lipid intermediates. Trial registration ClinicalTrials.gov NCT02782208 Funding The work was supported by the Grant for Growth Innovation (GGI), which was funded by Merck KGaA, Darmstadt, Germany. Graphical abstractFunding Information
- Merck KGaA (Grant for Growth Innovation (GGI))
This publication has 50 references indexed in Scilit:
- Mechanisms for Insulin Resistance: Common Threads and Missing LinksCell, 2012
- Effects of Growth Hormone and Free Fatty Acids on Insulin Sensitivity in Patients with Type 1 DiabetesJournal of Clinical Endocrinology & Metabolism, 2009
- PDH-E1α Dephosphorylation and Activation in Human Skeletal Muscle During ExerciseDiabetes, 2006
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006
- Enzymatic regulation of glucose disposal in human skeletal muscle after a high-fat, low-carbohydrate dietJournal of Applied Physiology, 2005
- Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fastingJournal of Applied Physiology, 2004
- The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjectsJCI Insight, 1999
- Interaction between glucose and free fatty acid metabolism in human skeletal muscle.JCI Insight, 1993
- Effect of Human Growth Hormone on Muscle and Adipose Tissue Metabolism in the Forearm of Man *JCI Insight, 1965
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSThe Lancet, 1963